RxDoctor Payments Data

Jacqueline Sperber

Family · Northvale, NJNPI 1669874939

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.5% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,248, 8.0 times the $156 reported in 2021. Among family clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,579in general payments, 2019–2025

Across 207 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$769
  • Incyte Corporation$400
  • Sun Pharmaceutical Industries Inc.$360
  • Sanofi$266
  • AbbVie$234
  • E.r. Squibb & Sons, L.L.C.$230
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,31092%
  • Education$2698%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,579 in reported general payments places this provider in the 90th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey →

Medicare billing

Part B allowed, 2024
$78,263
Medicare patients
303
Services billed
1,146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clindamycin Phosphate70$4,381
Ketoconazole124$2,658
Clobetasol Propionate64$2,165
Betamethasone Dipropionate32$1,614
Triamcinolone Acetonide123$1,409
Ciclopirox16$848
Halobetasol Propionate14$747
Metronidazole16$672
Hydrocortisone54$560
Doxycycline Hyclate13$389
Mupirocin49$298

Paid to pharmacies, not to this prescriber.

Other family in Northvale

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →